Key takeaways
There is no evidence that semaglutide directly affects the menstrual cycle.
Significant weight loss can mess with your menstrual cycle, which may be why some people say that semaglutide affects their periods.
Reducing body weight in a healthy, gradual manner can help regulate periods and improve fertility in people with obesity, PCOS, or both.
Rapidly reducing body weight can cause skipped periods, irregular periods, and infertility.
Anyone experiencing significant cycle changes on semaglutide should tell their healthcare provider, who can help pinpoint whether the symptoms may be due to weight loss on semaglutide or a medical condition.
Here's what we'll cover
Here's what we'll cover
Key takeaways
There is no evidence that semaglutide directly affects the menstrual cycle.
Significant weight loss can mess with your menstrual cycle, which may be why some people say that semaglutide affects their periods.
Reducing body weight in a healthy, gradual manner can help regulate periods and improve fertility in people with obesity, PCOS, or both.
Rapidly reducing body weight can cause skipped periods, irregular periods, and infertility.
Anyone experiencing significant cycle changes on semaglutide should tell their healthcare provider, who can help pinpoint whether the symptoms may be due to weight loss on semaglutide or a medical condition.
These days, semaglutide medications — specifically, Ozempic and Wegovy — have practically become household names. These GLP-1s are best known for their weight loss effects, but of course, they're not without other side effects. For instance, does semaglutide affect your period? There is no research that the drug itself messes with your period, but weight loss from semaglutide (or from other causes) can.
Here's what you need to know about semaglutide and the menstrual cycle.
Does semaglutide affect your period?
Semaglutide can affect your period — indirectly. Research on this topic is limited, but no clinical trial data suggest that semaglutide affects your period. Common semaglutide side effects do not include missed periods, irregular periods, spotting, or any other symptom of menstrual cycle disruption.
However, science shows a clear link between weight loss and changes in the menstrual cycle. So whether you're on semaglutide or not, you're not alone if your period got a bit wonky after a significant change in body weight.
How can semaglutide affect your period?
Does semaglutide affect your period? Again, there is no evidence that it directly impacts your menstrual cycle. But since semaglutide can cause significant, rapid weight loss, which can mess with your menstrual cycle, you may experience irregular cycles or even skip a period while using this medication.
While there's no guarantee that semaglutide will affect your period at all, here are some ways body weight changes from the medication might affect your cycle.
Skipped periods
A 2023 research review mentioned that losing 10%--15% of your body weight in a short period of time can cause amenorrhea, the medical term for missed periods.
And you can certainly lose a lot of weight on semaglutide. In clinical trials of Wegovy (a semaglutide medication), participants lost an average of 15% of their body weight (approximately 33 pounds, though individual results varied) within 68 weeks.
Now, let’s be very clear: Missed periods aren’t a direct effect of semaglutide. But some people taking the medication do, in fact, experience them because of the rapid weight loss from the drug.
Irregular periods
That same research review found that weight loss-related amenorrhea can last for months or even years. Whether you miss one period or several periods over the course of a year, periods that have become less regular are, by definition, irregular periods. When your menstrual cycle varies from month to month due to recent weight loss, it can be tough to predict your next period.
Point being: Semaglutide itself won't cause irregular periods. But it's not out of the ordinary to have irregular periods for a few months after reducing your body weight with the help of semaglutide. Make sure to tell your healthcare provider about any changes in your menstrual cycle.
Lighter flow
There isn't any evidence that semaglutide directly causes lighter periods. But research shows that obesity can increase the risk of heavy, painful periods. (FYI, heavy menstruation requires changing pads or tampons every 1–2 hours.) So, theoretically, if you have obesity and heavy periods, losing weight with the help of semaglutide may lighten your flow.
Shorter periods
For some people, a heavy period means soaking through many pads or tampons in a day. For others, it involves bleeding for 8–10 days (vs. the average of 3–7 days). Sound like you? Unfortunately, semaglutide won’t shorten your period. But if your heavy flow is caused by obesity or overweight, reducing your body weight with the help of semaglutide might do the trick.
More regulated periods
Obesity isn't just linked to heavier periods. Having a high body mass index (BMI) can also cause irregular periods by disrupting hormonal balance. There’s no guarantee, but in theory, this means losing weight on semaglutide could help restore more regular periods.
People diagnosed with polycystic ovary syndrome (PCOS) are even more likely to notice a more predictable cycle after losing weight on Wegovy or Ozempic. In a study of 27 women with obesity and PCOS, about 80% of participants reported more regular periods after taking low doses of semaglutide for three consecutive months.
Find out how much you could lose
Provide your biometric data to get started.

0.0
Your BMI
Underweight
< 18.5
Healthy weight
18.5 - 24.9
Overweight
24.9 - 29.9
Obesity
> 30
Lower PMS risk
There's no evidence that semaglutide itself can improve premenstrual syndrome (PMS). But research has linked having a high BMI — 27 or more — with a high PMS risk. Hypothetically, reducing your BMI by losing weight on semaglutide could dial down your risk of experiencing PMS symptoms like mood swings, irritability, bloating, and breast pain.
In other words, any potential decrease in PMS symptoms could be an indirect effect of the weight loss experienced with Wegovy or Ozempic.
Improved fertility
Fertility is a well-documented challenge for many people with obesity. A high BMI, along with an unhealthy diet and sedentary lifestyle, can impede your body's ability to get and stay pregnant.
So, what does that have to do with semaglutide? First, it’s important to know that there is no evidence to support semaglutide as a treatment for infertility. However, it is possible that losing weight with semaglutide could improve overall health, and a healthier lifestyle boosts the odds of a healthy pregnancy.
Infertility
While it's true that healthy weight loss can improve fertility, it's also true that significant, rapid weight loss can mess with ovulation, making it harder to get pregnant.
Here's the gist: Ovulation is the part of your cycle when the ovaries release an egg into the fallopian tube. If you're trying to get pregnant, you might know that this is the prime time and place for a meet-cute between egg and sperm.
But if recent body weight changes have messed with your cycle, it's difficult to predict your "fertile window." Finally, it's also true that weight loss-related amenorrhea might involve skipping ovulation entirely. This equates to a missed period — and a missed opportunity for conception, if that is your goal. In most cases, these changes are temporary, and your menstrual cycle may return to normal as your body adjusts to the new weight.
Can semaglutide make you miss a period?
Again, not directly. There is no evidence that semaglutide itself causes missed periods. But weight loss-related amenorrhea is absolutely a thing. Semaglutide causes weight loss, so it makes sense that some women on semaglutide report missed periods.
What to do if you experience menstrual cycle changes on semaglutide
Minor menstrual cycle changes on semaglutide, such as a lighter-than-normal period or bleeding that stops a day or two before expected, are not usually cause for concern. Some cycle changes can even be a positive sign, like when losing body weight helps regulate your periods or lighten up a heavy, painful flow.
That said, persistent, painful, or significant cycle changes should be reported to a healthcare professional. Skipping several periods, bleeding between periods, or experiencing heavier or prolonged bleeding can be signs of underlying health conditions. For instance, missed periods can indicate that you're undernourished — or even that you're pregnant. Mid-cycle spotting or increasingly heavy periods can be a red flag for polyps, hormone imbalance, bleeding disorders, and more.
Ultimately, you know your body best. Dealing with a missed period? Consider taking a pregnancy test — it can’t hurt. It’s always a good idea to seek personalized medical advice if you're concerned about period changes on semaglutide. Cycle changes may be simply caused by semaglutide-related weight loss, but they may also be a symptom of a more serious health condition. And if you are experiencing missed periods, your healthcare provider may want to reduce your semaglutide dosing.
Bottom line
Some Wegovy users and Ozempic users say that being on these semaglutide drugs changed their menstrual cycles. But can semaglutide affect your period? Only indirectly.
Here's the recap:
There's no direct connection between semaglutide and the menstrual cycle. There's no research suggesting that semaglutide messes with your period. The mostcommon semaglutide side effects are gastrointestinal, not gynecological.
Weight loss from semaglutide can impact your cycle. Studies have shown that significant weight loss can cause changes in the menstrual cycle, ranging from missed periods and lighter flow to fertility changes and more regular periods.
It's a good idea to report persistent changes to your provider. Weight loss from semaglutide can impact your cycle, but missed periods, spotting, and increased bleeding might also indicate a health problem like PCOS or polyps. Talk to a healthcare professional if you notice any significant or persistent cycle changes.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Bertone-Johnson, E. R., Hankinson, S. E., Willett, W. C., et al. (2010). Adiposity and the development of premenstrual syndrome. Journal of Women's Health (2002), 19(11), 1955–1962. doi: 10.1089/jwh.2010.2128. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2971655/
Carmina, E. & Longo, R. A. (2023). Semaglutide Treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs. Journal of Clinical Medicine, 12(18), 5921. doi: 10.3390/jcm12185921. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10531549/
Chen, L., Lu, Y., Zhou, Y. F., et al.(2023). The effects of weight loss-related amenorrhea on women's health and the therapeutic approaches: a narrative review. Annals of Translational Medicine, 11(2), 132. https://doi.org/10.21037/atm-22-6366. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929756/
Eunice Kennedy Shriver National Institute of Child Health and Human Development. (2022). What lifestyle and environmental factors may be involved with infertility in females and males? Retrieved on Aug. 29, 2025 from https://www.nichd.nih.gov/health/topics/infertility/conditioninfo/causes/lifestyle
Falsetti, L., Pasinetti, E., Mazzani, M. D., et al. (1992). Weight loss and menstrual cycle: clinical and endocrinological evaluation. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 6(1), 49–56. doi: 10.3109/09513599209081006. Retrieved from https://pubmed.ncbi.nlm.nih.gov/1580168/
Gautam, D., Purandare, N., Maxwell, C. V., et al. (2023). The challenges of obesity for fertility: A FIGO literature review. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 160 Suppl 1(Suppl 1), 50–55. doi: 10.1002/ijgo.14538. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10107441/
Institute for Quality and Efficiency in Health Care. (2025). Overview: heavy periods. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK279294/.
Itriyeva, K. (2022). The effects of obesity on the menstrual cycle. Current Problems in Pediatric and Adolescent Health Care, 52(8), 101241. doi: 10.1016/j.cppeds.2022.101241. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9449629/
Ko, K. M., Han, K., Chung, Y. J., et al. (2017). Association between Body Weight Changes and Menstrual Irregularity: The Korea National Health and Nutrition Examination Survey 2010 to 2012. Endocrinology and Metabolism (Seoul, Korea), 32(2), 248–256. doi: 10.3803/EnM.2017.32.2.248. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5503870/
Premenstrual syndrome. (2025). Office on Women’s Health. Retrieved from https://www.womenshealth.gov/menstrual-cycle/premenstrual-syndrome
Reavey, J. J., Walker, C., Murray, A. A., et al. (2021). Obesity is associated with heavy menstruation that may be due to delayed endometrial repair. The Journal of Endocrinology, 249(2), 71–82. doi: 10.1530/JOE-20-0446. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33836495/
Ryan, D. H. & Yockey, S. R. (2017). Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Current Obesity Reports, 6(2), 187–194. doi: 10.1007/s13679-017-0262-y. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5497590/
Thiyagarajan, D., Basit, H., & Jeanmonod, R. (2024). Physiology, menstrual cycle. StatPearls. Retrieved on Aug. 29, 2025 from https://www.ncbi.nlm.nih.gov/books/NBK500020/
Wiggs, A. G., Chandler, J. K., Aktas, A., et al. (2021). The Effects of Diet and Exercise on Endogenous Estrogens and Subsequent Breast Cancer Risk in Postmenopausal Women. Frontiers in Endocrinology, 12, 732255. doi: 10.3389/fendo.2021.732255. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8489575/
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33567185/